Clarification Post.... Reading my previous post where I

New Post Public Reply Private Reply Replies (1) Message Board
joey68 joey68 #859
Clarification Post....

Reading my previous post where I said, "ultimately, a buyout is the only option", I didn't mean that in a negative way. Read all my old DD and youll see why I think this.

SCIE management's average age is in their upper 60's at least. These guys are seasoned professionals. More than likely, Oliver doesn't want to sit at a desk in his retirement days. He wants to bask in the sunshine knowing that he turned a crap company into a multi-million dollar business by selling it to a mega company.

Remember, way before Oliver came on the scene, SCIE was a complete mess.

My post from August 2016:

Quote:
The company has been around for a very long time but the majority of the previous years were a mess. They were working on a LUMA device which doesnt even exist anymore, management was a mess.. Oliver became the CEO only a few short years ago...the list goes on and on. Oliver even admitted in a video that SCIE lost over a year trying to penetrate the UK on their own.


(The video is posted in one of my old posts)

In my opinion, believing that a buyout is the ultimate goal makes it much simpler to invest in SCIE.

My post from April 2016:

Quote:
I'm not in love with Spectrascience. I see their technology filling a global need, and this will make me a profit.


This is what is important to me. There are pennystocks out there trying to sell pancake batter. Could it succeed? Sure it could. Is there a global need for it. No. There is a global need for better cancer detection technology. SCIE has a working device which does just that.

Remember the last 10Q? "Over $4 million are in default owned by 79 investors."

That's what makes me believe in this company. These 79 people are real individuals. They could easily give up on SCIE and demand their money back; but they don't. Its my belief these investors know SCIE has a very good chance of succeeding and are allowing them time to do their stuff.

This post isn't me telling anyone to "stick it out with SCIE" or "buy on the dips". Everyone needs to do what they feel is best for themselves. This post is me stating my opinion.

Could SCIE fail miserably? Sure it could. Its a stock. Will it? I don't think it will. Investors are extremely dramatic, fickle people who will love their positions one day and despise them the next; only to re-love them the very next day once a PR comes out. But investing based on emotion alone almost always equates to loss.

SCIE is current. We haven't received any bad PRs.

Medtech is in January.

The MORDIS trial is still current.

Quote:
ClinicalTrials.gov processed this record on December 06, 2016


https://clinicaltrials.gov/ct2/show/NCT01980134

Some of the top people in the field are investigating the WavSTAT.

Does all of this information 'insist' investors remain invested in SCIE? Of course not. We can all sell just as easily as we can buy. Ive said it many times - Being 'long' in a stock doesn't have to mean holding forever. Sell if you think its good to sell, and then jump back in when the price is lower. Heck, I'm long in many stocks that I'm not invested in.

That's the issue with online investing and these crazy investment boards. We constantly read people saying "Buy on the dips!", "Hold!", "Gift prices!", "I'm long forever!"....

Long forever? What does that even mean? Like BLTA? A stock which, two years ago, I shared my opinion in these boards that it was time to sell; sold at the high; mocked by BLTA investors that I made the 'wrong decision' (even now if I try to post, my posts are automatically deleted because they aren't 'feel good pro-BLTA centered).. and yet its been downhill ever since. A stock that's pretty much dead, yet investors insist its going to somehow magically succeed. A stock that investors know in their gut will probably never make their money back, yet they insist on not selling at a loss. But hey, to each their own; maybe BLTA will skyrocket in price..........

ive made a number of poor investment decisions in my life as well, and investing is a learning experience.

But that's the main point of this ridiculously, drawn out post. Investing is about LEARNING. If we constantly find ourselves never selling on time before the price crashes, we have two choices:

1. Keep doing the same thing
or
2. Learn why it keeps happening, adjust your investment strategies, and continue on.

Has anyone besides myself noticed there is not a shred of DD going on in the SCIE boards anymore? Why not? I'm sure theres something new out there.

Remember China Forum VI in January 2016?
http://www.omcconference.com/

The requirements for this program is:

•FDA or CE approved products
•Breakthroughs nearing commercialization
•No current exclusive Chinese representation

Doesn't SCIE fall under those categories? Although this is pure guesswork, is it possible SCIE is working with companies in China?

On the webpage, it states:

Quote:

663 A medical device company that offers a simplified yet highly effective way of diagnosing colorectal cancer early, when recovery rates are highest. Their WavSTAT Optical Biopsy System ® uses light to determine tissue health, and instantly detects if tissue is normal, pre-cancerous or cancerous without the need for a costly physical biopsy


Which means SCIE is doing something, was doing something, or is trying to do something with China.

Is it possible there will be a China Forum VII in early 2017? Time will tell.

Do NOT invest based on this post. Although I don't post here much, its not because I don't believe in the company. Its because I don't have to convince myself anymore.

I stand by my saying of Do not invest more than you can afford to lose.
Not investment advice

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

InsCorp's Steady Q3 Climb Mirrors Strategic Focus

Updated Category News Views 46

Riding the Revenue Wave Now we're talking about a bank knowing their business—InsCorp, Inc. recently flaunted a 12% year-on-year revenue bump for 3Q26, a testament to a strategy that's clearly sticking. Still, while those numbers are nice and shiny, the detailed breakdown shows earnings per share (EPS) barely budged from last quarter, coming in at $0.73, just a hair...

Continue Reading
Nanoscope Therapeutics Aims for Eye-Catching Advances

Updated Category News Views 87

Gearing Up for a Boston Showcase Nanoscope's High-Stakes Boston Rendezvous In a move set to grab some serious eyeballs, Nanoscope Therapeutics is geared up to strut their stuff at Advanced Therapies USA 2026 in Boston. Scheduled for November 4–5 at the Hynes Convention Center, the event isn't just another pitstop—it's a billboard for what these guys have cooking. With...

Continue Reading
Kuvings Unveils Hands-Free Juicer for Healthy Living

Updated Category News Views 96

A Fresh Squeeze in the Juice World If you've ever wanted something that makes that morning juice without you running a marathon in your own kitchen, Kuvings might just have the answer with their new AUTO10 SQUARE™ Plus. Announced on October 30, 2026, this isn't just another fancy named gadget—it actually shakes things up with a hands-free design that’s tailored for...

Continue Reading
CMRE Facing Legal Heat Over Wage Allegations

Updated Category News Views 10

Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...

Continue Reading
Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ

Updated Category News Views 64

Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...

Continue Reading
Bybit Unveils Platform Vision at HK FinTech Week

Updated Category News Views 63

Bybit's Strategic Participation at HK FinTech Week Here’s what’s got everyone buzzing: Bybit is stepping onto the big stage at the Hong Kong FinTech Week 2026. We're talking about the crème de la crème of fintech gatherings, where the sharpest minds of the financial world mingle, munch, and strategize under the buzzing neon of Hong Kong. Bybit's involvement is no...

Continue Reading
WHI's Nexus AI Transforms Phone Ordering in Parts Biz

Updated Category News Views 174

Nexus AI: The New Frontline for Part Distributors In a move poised to shake up the auto parts distribution scene, WHI Solutions, a child of eBay, is rolling out a game-changer: the Nexus AI suite designed for the Nexpart platform. Now, tech and tradition blend as AI tackles phone ordering for those early-morning rushes and late-night calls. A Solution for Your Busiest...

Continue Reading
Texas Home Boasts PGA-Caliber Green with Synthetic Turf

Updated Category News Views 40

Swinging for Luxury in Your Backyard Who'd have thought that a chunk of Austin, Texas, could boast a putting green that’s giving any PGA course a run for its money? We’re talking about a family here who decided they’d had enough of scalding summers and winter chills and wanted a taste of that country club glam at home without the upkeep headaches. The Rise of...

Continue Reading
California Housing Affordability Stagnant as Rates Rise

Updated Category News Views 55

Numbers Tell the Story Get this: California's housing market's as sticky as day-old gum on a hot sidewalk. Despite a dip in home prices, affordability just won't budge. The California Association of REALTORS® (C.A.R.) says 19% of households could afford a median-priced home at $894,630, exactly like last quarter and even a year back. Not a flicker of change. Quirky it...

Continue Reading
Endava's Securities Class Action Heats Up Wall Street

Updated Category News Views 13

A Head-Spinning Fall for Endava Endava's recent tumble on the NYSE has investors rubbing their eyes in disbelief. A jaw-dropping 25% slide in share value on September 22, 2026, has everyone scrambling for answers. Looks like some serious skeletons were hiding deep in Endava's closets—management snafus and fuzzy accounting being at the forefront. This debacle has peeled...

Continue Reading

Top 5 Most Recently Viewed Articles

Wells Fargo & Co Short Interest Insights and Impact

Updated Category News Views 207

Understanding the Recent Movement in Wells Fargo & Co's Short Interest Wells Fargo & Co (NYSE: WFC) has seen a notable decrease in its short interest as a percentage of its float. Recent reports indicate that this short interest has declined by 21.17%, now tallying 34.57 million shares sold short. This represents about 1.08% of all the regular shares available for...

Continue Reading
Encryption as a Service Experience Exceptional Market Growth

Updated Category News Views 121

Exploring the Rapid Growth of Encryption as a Service The Encryption as a Service market is undergoing significant transformation as businesses embrace more robust security measures. With the global market projected to soar from USD 1.57 billion in the coming year to an impressive USD 5.98 billion by 2030, this growth is primarily driven by accelerated cloud adoption and...

Continue Reading
Unlocking Maximum Profits with BexBack's Trading Features

Updated Category News Views 129

Seizing Crypto Trading Opportunities with BexBack As cryptocurrencies gain renewed momentum, savvy traders are exploring innovative platforms to take advantage of market fluctuations. BexBack, a front-runner in the crypto futures arena, is leading the charge with compelling offerings designed to enhance trading experiences. Recent trends indicate that with Bitcoin...

Continue Reading
Liminal Health Unveils NSA ClearPath for Better Reimbursements

Updated Category News Views 389

Transforming Reimbursement with NSA ClearPath Liminal Health is thrilled to unveil NSA ClearPath, an innovative software solution specifically designed to support out-of-network healthcare providers in navigating the complexities of the No Surprises Act (NSA). This groundbreaking platform emphasizes automation, scalability, and transparency, equipping healthcare providers...

Continue Reading
New Found Gold Sees Exciting Drill Results at Dropkick Zone

Updated Category News Views 212

Exciting Drill Results from New Found Gold Corp. New Found Gold Corp. (TSXV: NFG) recently delivered promising results derived from five diamond drill holes in a step-out program at the Dropkick Zone, part of their larger exploration efforts. This area is situated within the Kingsway property, a strategic asset in the company's portfolio. The latest findings indicate...

Continue Reading